News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elan Pharmaceuticals (ELN) Selects Medidata Solutions, Inc. Rave(R) to Support Clinical Development Activities


12/17/2007 9:09:34 AM

Medidata Solutions today announced that Elan Pharmaceuticals, Inc. has selected Medidata Rave as its electronic data capture (EDC), management and reporting solution. Elan plans to begin using Rave in mid- and late-stage clinical studies in North America.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES